As of 2025-09-16, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (36.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -2492.8%.
The range of the Relative Valuation is (20.54) - (58.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 34.4x | 21.1x |
| Forward P/E multiples | 12.0x - 34.1x | 22.1x |
| Fair Price | (20.54) - (58.14) | (36.85) |
| Upside | -1433.8% - -3875.3% | -2492.8% |
| Date | P/E |